Our study provides a new evidence that butyrate could ameliorate the progression of inflammation in atherosclerosis through regulating macrophage polarization via GPR43-related and HDAC/PPAR-γ/NF-κB/NLRP3/miRNAs signal pathways. The gene discussed is NFKB1; the disease is atherosclerosis.